The Clinical Study of Carrimycin on Treatment Patients With COVID-19

NCT04286503 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

520

Enrollment

OTHER

Sponsor class

Conditions

Novel Coronavirus Infectious Disease (COVID-19)

Interventions

DRUG: Carrimycin
DRUG: lopinavir/ritonavir tablets or Arbidol or chloroquine phosphate
DRUG: basic treatment

Sponsor

Beijing YouAn Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]